← Back to Search

Cell Saver for Chronic Low Back Pain

N/A
Waitlist Available
Led By Mladen Djurasovic, MD
Research Sponsored by Norton Leatherman Spine Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up post-operative, range of 1 to 14 days
Awards & highlights

Summary

The purpose of this study is to determine the cost-effectiveness of using a cell saver for 2 to 3 level lumbar fusions. A secondary objective is to determine if there will be a decrease in the number of allogenic blood transfusions when a cell saver is used intraoperatively. Another secondary objective is to determine incidence of complications associated with cell saver use and transfusions.

Eligible Conditions
  • Chronic Low Back Pain

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~post-operative, range of 1 to 14 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and post-operative, range of 1 to 14 days for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Volume of blood transfused
Secondary study objectives
Immediate post-op Hematocrit level
Immediate post-op Hemoglobin level

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Cell SaverActive Control1 Intervention
Patients will have the use of a cell-saver during surgery
Group II: No Cell saverPlacebo Group1 Intervention
Patient will not have cell saver available during surgery.

Find a Location

Who is running the clinical trial?

Norton Leatherman Spine CenterLead Sponsor
5 Previous Clinical Trials
537 Total Patients Enrolled
Mladen Djurasovic, MDPrincipal InvestigatorNorton Leatherman Spine Center
~17 spots leftby Sep 2025